Cochlear Ltd
XMUN:OC5
Cochlear Ltd
XMUN:OC5
Price:
89.86
EUR
2.64%
Market Closed
Market Cap:
€3.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
Cochlear Ltd
XMUN:OC5
|
AU |
|
Imperial Equities Inc
XTSX:IEI
|
CA |
|
Quantum Cyber NV
NASDAQ:QUCY
|
DE |
|
G
|
Gen Digital Inc
XHAN:SYM
|
US |
|
Crrc Corp Ltd
OTC:CRCCY
|
CN |
|
G
|
Golden Ocean Group Ltd
F:KT31
|
BM |
|
E
|
Epiroc AB
OTC:EPIAF
|
SE |
| Metric | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.3B | 1.4B | 1.4B | 1.3B | 1.5B | 1.6B | 1.9B | 2.2B | 2.3B | 2.3B | |
| (351.8m) | (358.4m) | (344.5m) | (336.2m) | (398.7m) | (397.9m) | (488m) | (562.1m) | (615.2m) | (688m) | |
| 902.1m | 1B | 1.1B | 984.4m | 1.1B | 1.3B | 1.4B | 1.7B | 1.7B | 1.7B | |
| (578m) | (657.3m) | (722.7m) | (743.4m) | (743m) | (856.4m) | (1B) | (1.2B) | (1.2B) | (1.2B) | |
| (430.1m) | (494.4m) | (545.7m) | (563.8m) | (556.3m) | (657.7m) | (810.4m) | (897.6m) | (939.9m) | (928.2m) | |
| (151.9m) | (167.7m) | (184.4m) | (185.1m) | (195m) | (210.7m) | (244.9m) | (277m) | (291.5m) | (323.2m) | |
| 4.1m | 4.8m | 7.4m | 5.5m | 8.3m | 12m | 13.5m | 10.7m | 26.4m | 13.3m | |
| 324.1m | 348m | 359.5m | 241m | 355.9m | 394m | 406.3m | 509.6m | 522.9m | 421.5m | |
| (6.4m) | (10m) | 1.9m | (7.2m) | 26.1m | 11.2m | (9.7m) | 3.1m | (4.4m) | (113.3m) | |
| 7.5m | 8.5m | 5.2m | 10.5m | 12m | 8.6m | 9.4m | 9.2m | 11m | 13.2m | |
| (8.9m) | 2.5m | 4.2m | (504.9m) | (16.3m) | (11.4m) | 0 | (27.9m) | 0 | (94.3m) | |
| 308.8m | 340.5m | 365.6m | (271.1m) | 365.7m | 393.8m | 396.6m | 484.8m | 518.5m | 213.9m | |
| (85.2m) | (88.4m) | (88.9m) | 32.8m | (39.2m) | (104.7m) | (96m) | (128m) | (129.6m) | (66.6m) | |
| 223.6m | 252.1m | 276.7m | (238.3m) | 326.5m | 289.1m | 300.6m | 356.8m | 388.9m | 147.3m | |
| 223.6m | 245.8m | 276.7m | (238.3m) | 326.5m | 289.1m | 300.6m | 356.8m | 388.9m | 147.3m | |
| 3.89 | 4.26 | 4.79 | (4.00) | 4.97 | 4.40 | 4.56 | 5.43 | 5.93 | 2.25 |
An acquisition-supported medtech compounder with improving margins and uneven cash conversion
Rapid revenue expansion alongside persistent operating losses and external funding dependence
A development-stage inhalation platform reliant on project income and equity funding
A fast-growing medtech platform still funding expansion through losses and equity
Continue OC5 Research
Other Cochlear Ltd listings: